drugset / Trial / NCT06728644

The Role of L-arginine in Polycystic Ovary Syndrome

NCT06728644

Completed 31 enrolled Shanghai 10th People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

PCOS patients meeting the trial criteria were enrolled from the Shanghai 10th People's Hospital. The contents of this study were introduced to them, and they were invited to participate in the study. We further evaluated the efficacy and safety of arginine in treating PCOS by implementing the L-arginine clinical intervention protocol, and conducting post-intervention follow-up, efficacy evaluation, laboratory tests, and fecal sample 16S rRNA sequencing.

Timeline

Start
2024-07-14
Primary completion
2025-07-04
Completion
2025-07-04

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 3 g